Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of options, PDMR notification & TVR

8 Nov 2022 07:00

RNS Number : 6005F
ThinkSmart Limited
08 November 2022
 

8 November 2022

 

 

ThinkSmart Limited

("ThinkSmart" or the "Company" and together with its subsidiaries the "Group")

 

Exercise of Options, Issue of Ordinary Shares, Total Voting Rights and Director/PDMR Shareholding Notification

ThinkSmart (AIM: TSL) announces that following the exercise of awards granted under the ThinkSmart Long Term Incentive Plan 2016 the Company has issued 500,000 ordinary shares of no par value each in the Company ("Ordinary Shares") under the Company's block listing facility. These have all been issued to Ned Montarello, Executive Chairman of ThinkSmart, who exercised awards at £0.1308 per share. Following the above, Mr Montarello, and entities he is related to, now hold 31,842,286 shares representing 29.57% of the issued share capital.

 

Total Voting Rights

The Company advises that, following the issue of the 500,000 new ordinary shares, the Company's issued share capital will be 107,693,483 Ordinary Shares. The Company holds no shares in Treasury. Therefore, the total number of voting rights in the Group will be 107,693,483.

 

This gure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the Disclosure Guidance and Transparency Rules of the FCA.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ned Montarello

2

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

ThinkSmart Limited

b)

LEI

213800ZBZQVXHDZHET73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of NPV each in the Company

 

Identification code

AU000XINEAE8

b)

Nature of the transaction

Exercise of 500,000 awards at £0.1308 under the ThinkSmart Limited Long Term Incentive Plan. 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.1308

500,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

7 November 2022 

f)

Place of the transaction

Outside a trading venue

 

 

For further information please contact:

ThinkSmart Limited

Via Buchanan

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

+44 (0)20 7523 8350

Emma Gabriel

Andrew Potts

Tom Diehl

Buchanan

+44 (0)20 7466 5000

Giles Stewart

Chris Lane

Toto Berger

 

 

Notes to Editors

 

About ThinkSmart Limited

 

ThinkSmart's roots are as a specialist digital payments platform business. Following the sale of its remaining 10% shareholding in Clearpay in January 2022, the Group holds shares in NYSE listed Block, Inc (NYSE: SQ). The Group also provides an outsourced call centre customer service and support service to Clearpay and is managing the wind-down of its leasing business.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKOBNDBDBFDK
Date   Source Headline
22nd Dec 20164:42 pmRNSBuy-back class ruling
22nd Dec 20163:05 pmRNSGrant of LTIP Awards
16th Dec 20168:02 amRNSAppointment of Joint Corporate Broker
15th Dec 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20165:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Dec 20167:00 amRNSChange in ISIN and SEDOL
2nd Dec 20168:06 amRNSAdmission to AIM and First Day of Dealings
21st Apr 20082:47 pmRNSIssue of Equity-TissueScience
8th Apr 20082:26 pmRNSTissue Science Equity Issue
2nd Apr 20084:44 pmRNSTissue Science Laboratories
2nd Apr 200812:18 pmRNSTissue Science Laboratories
1st Apr 20087:57 amRNSEPT Disclosure
28th Mar 20083:26 pmRNSHolding(s) in Company
28th Mar 200812:02 pmRNSHolding(s) in Company
28th Mar 20087:02 amRNSRule 8.1- Tissue Science Lab
27th Mar 200811:41 amRNSHolding(s) in Company
27th Mar 20089:47 amRNSRule 8.1 - Tissue Science Lab
25th Mar 20087:01 amRNSRule 8.1- Tissue Science Lab.
19th Mar 200811:29 amRNSHolding(s) in Company
19th Mar 20089:29 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:25 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:22 amRNSRule 8.1- Tissue Science Lab.
14th Mar 20084:31 pmRNSRule 8.3- Tissue Science
14th Mar 20082:21 pmRNSRule 8.3- Tissue Science
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:15 amRNSRule 8.3- Tissue Science
14th Mar 20088:09 amRNSRule 8.1- Tissue Science Lab
13th Mar 20082:26 pmBUSRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20082:05 pmRNSRule 8.1- Tissue Science Lab.
13th Mar 20081:07 pmRNSEPT Disclosure-Amend
13th Mar 200811:05 amPRNRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20088:36 amRNSEPT Disclosure
13th Mar 20087:00 amRNSRule 8.1- Tissue Science Lab.
12th Mar 20083:55 pmRNSOffer Document Posted
12th Mar 20087:01 amRNSOffer for Tissue Science Lab.
12th Mar 20087:01 amRNSFinal Results & Cash Offer
17th Jan 20087:00 amRNSPositive Study Results
12th Nov 200710:47 amRNSHolding(s) in Company
7th Nov 20074:22 pmRNSHolding(s) in Company
28th Sep 20077:02 amRNSInterim Results
10th Sep 20077:01 amRNSNotice of Results
28th Aug 200712:26 pmRNSHolding(s) in Company
17th Aug 20073:28 pmRNSAIM Rule 26 Compliance
6th Jul 20072:25 pmRNSResult of AGM
6th Jul 20077:00 amRNSPre-close Trading Statement
29th Jun 20074:00 pmRNSTotal Voting Rights
14th Jun 20077:00 amRNSNotice of AGM
31st May 200712:00 pmRNSExercising of Options
16th Apr 20077:01 amRNSR&D Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.